Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors NCT00075439 Gastrinoma
Glucagonoma
Insulinoma
Metastatic Gast...
Pancreatic Poly...
Recurrent Gastr...
Recurrent Islet...
Somatostatinoma
WDHA Syndrome
gefitinib
laboratory biom...
18 Years - National Cancer Institute (NCI) View Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer NCT00005842 Cancer
trastuzumab
tipifarnib
18 Years - National Cancer Institute (NCI) View Temozolomide and Pazopanib Hydrochloride in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery NCT01465659 Pancreatic Alph...
Pancreatic Beta...
Pancreatic Delt...
Pancreatic G-ce...
Recurrent Islet...
temozolomide
pazopanib hydro...
18 Years - Northwestern University View Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors NCT00602082 Gastrointestina...
Islet Cell Tumo...
capecitabine
cisplatin
streptozocin
DNA analysis
RNA analysis
protein analysi...
proteomic profi...
laboratory biom...
18 Years - National Cancer Institute (NCI) View Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum NCT00005860 Cancer
floxuridine
leucovorin calc...
oxaliplatin
18 Years - National Cancer Institute (NCI) View Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders NCT00830557 Islet Cell Tumo...
Pancreatic Canc...
Pancreatic Dise...
medical chart r...
survey administ...
biospecimen col...
18 Years - 120 Years Mayo Clinic View Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By Surgery NCT00416767 Gastrointestina...
Islet Cell Tumo...
Neoplastic Synd...
fluorouracil
irinotecan hydr...
leucovorin calc...
18 Years - 80 Years Federation Francophone de Cancerologie Digestive View Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors NCT00227617 Gastrointestina...
Islet Cell Tumo...
Lung Cancer
Neoplastic Synd...
Neuroendocrine ...
bevacizumab
5-fluorouracil
leucovorin
oxaliplatin
18 Years - University of California, San Francisco View Thalidomide in Treating Patients With Metastatic Neuroendocrine Tumors NCT00027638 Gastrointestina...
Islet Cell Tumo...
Lung Cancer
Neoplastic Synd...
thalidomide
- Memorial Sloan Kettering Cancer Center View Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors NCT00227773 Gastrointestina...
Islet Cell Carc...
octreotide acet...
vatalanib
anti-cytokine t...
antiangiogenesi...
biological ther...
endocrine thera...
enzyme inhibito...
growth factor a...
hormone therapy
protein tyrosin...
somatostatin an...
18 Years - 120 Years Eastern Cooperative Oncology Group View Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors NCT02259725 Gastrinoma
Glucagonoma
Insulinoma
Metastatic Gast...
Pancreatic Poly...
Pulmonary Carci...
Recurrent Gastr...
Recurrent Islet...
Somatostatinoma
regorafenib
laboratory biom...
18 Years - University of Southern California View Thalidomide in Treating Patients With Metastatic Neuroendocrine Tumors NCT00027638 Gastrointestina...
Islet Cell Tumo...
Lung Cancer
Neoplastic Synd...
thalidomide
- Memorial Sloan Kettering Cancer Center View Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors NCT01155258 Extensive Stage...
Hereditary Para...
Male Breast Can...
Malignant Parag...
Metastatic Gast...
Metastatic Pheo...
Pancreatic Poly...
Recurrent Breas...
Recurrent Cervi...
Recurrent Endom...
Recurrent Gastr...
Recurrent Islet...
Recurrent Neuro...
Recurrent Non-s...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Pheoc...
Recurrent Prost...
Recurrent Renal...
Recurrent Small...
Recurrent Uteri...
Regional Gastro...
Regional Pheoch...
Stage III Cervi...
Stage III Endom...
Stage III Neuro...
Stage III Ovari...
Stage III Ovari...
Stage III Prost...
Stage III Renal...
Stage III Uteri...
Stage IIIA Brea...
Stage IIIA Non-...
Stage IIIB Brea...
Stage IIIB Non-...
Stage IIIC Brea...
Stage IV Breast...
Stage IV Endome...
Stage IV Neuroe...
Stage IV Non-sm...
Stage IV Ovaria...
Stage IV Ovaria...
Stage IV Prosta...
Stage IV Renal ...
Stage IV Uterin...
Stage IVA Cervi...
Stage IVB Cervi...
Thyroid Gland M...
temsirolimus
vinorelbine dit...
18 Years - University of Southern California View Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer NCT00005842 Cancer
trastuzumab
tipifarnib
18 Years - National Cancer Institute (NCI) View Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney Cancer NCT02273752 Estrogen Recept...
Gastrinoma
Glucagonoma
HER2-negative B...
Insulinoma
Mucositis
Oral Complicati...
Pancreatic Poly...
Progesterone Re...
Recurrent Breas...
Recurrent Islet...
Recurrent Renal...
Somatostatinoma
Stage III Renal...
Stage IIIA Brea...
Stage IIIB Brea...
Stage IIIC Brea...
Stage IV Breast...
Stage IV Renal ...
Everolimus
18 Years - Emory University View Temsirolimus in Treating Patients With Metastatic Neuroendocrine Carcinoma NCT00093782 Metastatic Gast...
Pulmonary Carci...
Recurrent Gastr...
Recurrent Islet...
temsirolimus
laboratory biom...
18 Years - National Cancer Institute (NCI) View Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors NCT01155258 Extensive Stage...
Hereditary Para...
Male Breast Can...
Malignant Parag...
Metastatic Gast...
Metastatic Pheo...
Pancreatic Poly...
Recurrent Breas...
Recurrent Cervi...
Recurrent Endom...
Recurrent Gastr...
Recurrent Islet...
Recurrent Neuro...
Recurrent Non-s...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Pheoc...
Recurrent Prost...
Recurrent Renal...
Recurrent Small...
Recurrent Uteri...
Regional Gastro...
Regional Pheoch...
Stage III Cervi...
Stage III Endom...
Stage III Neuro...
Stage III Ovari...
Stage III Ovari...
Stage III Prost...
Stage III Renal...
Stage III Uteri...
Stage IIIA Brea...
Stage IIIA Non-...
Stage IIIB Brea...
Stage IIIB Non-...
Stage IIIC Brea...
Stage IV Breast...
Stage IV Endome...
Stage IV Neuroe...
Stage IV Non-sm...
Stage IV Ovaria...
Stage IV Ovaria...
Stage IV Prosta...
Stage IV Renal ...
Stage IV Uterin...
Stage IVA Cervi...
Stage IVB Cervi...
Thyroid Gland M...
temsirolimus
vinorelbine dit...
18 Years - University of Southern California View Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors NCT00075439 Gastrinoma
Glucagonoma
Insulinoma
Metastatic Gast...
Pancreatic Poly...
Recurrent Gastr...
Recurrent Islet...
Somatostatinoma
WDHA Syndrome
gefitinib
laboratory biom...
18 Years - National Cancer Institute (NCI) View Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors NCT00466856 Head and Neck C...
Islet Cell Tumo...
Metastatic Canc...
Pheochromocytom...
octreotide acet...
yttrium Y 90 re...
18 Years - Vanderbilt-Ingram Cancer Center View Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders NCT00830557 Islet Cell Tumo...
Pancreatic Canc...
Pancreatic Dise...
medical chart r...
survey administ...
biospecimen col...
18 Years - 120 Years Mayo Clinic View Dovitinib Lactate in Treating Patients With Pancreatic Neuroendocrine Tumors NCT02108782 Gastrinoma
Glucagonoma
Insulinoma
Pancreatic Poly...
Recurrent Islet...
Somatostatinoma
dovitinib lacta...
pharmacological...
laboratory biom...
18 Years - Academic and Community Cancer Research United View Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors NCT00131911 Gastrinoma
Glucagonoma
Insulinoma
Metastatic Gast...
Neuroendocrine ...
Pancreatic Poly...
Recurrent Gastr...
Recurrent Islet...
Somatostatinoma
WDHA Syndrome
sorafenib tosyl...
18 Years - National Cancer Institute (NCI) View Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By Surgery NCT00416767 Gastrointestina...
Islet Cell Tumo...
Neoplastic Synd...
fluorouracil
irinotecan hydr...
leucovorin calc...
18 Years - 80 Years Federation Francophone de Cancerologie Digestive View AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors NCT00427349 Gastrointestina...
Islet Cell Tumo...
Neoplastic Synd...
AMG 706
octreotide
18 Years - Eastern Cooperative Oncology Group View AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors NCT00427349 Gastrointestina...
Islet Cell Tumo...
Neoplastic Synd...
AMG 706
octreotide
18 Years - Eastern Cooperative Oncology Group View Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors NCT00227773 Gastrointestina...
Islet Cell Carc...
octreotide acet...
vatalanib
anti-cytokine t...
antiangiogenesi...
biological ther...
endocrine thera...
enzyme inhibito...
growth factor a...
hormone therapy
protein tyrosin...
somatostatin an...
18 Years - 120 Years Eastern Cooperative Oncology Group View Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors NCT02259725 Gastrinoma
Glucagonoma
Insulinoma
Metastatic Gast...
Pancreatic Poly...
Pulmonary Carci...
Recurrent Gastr...
Recurrent Islet...
Somatostatinoma
regorafenib
laboratory biom...
18 Years - University of Southern California View Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer NCT00006368 Brain and Centr...
Breast Cancer
Gastrointestina...
Islet Cell Tumo...
Lung Cancer
Lymphoma
Melanoma (Skin)
Neoplastic Synd...
yttrium Y 90-ed...
18 Years - Novartis View Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors NCT00084461 Gastrinoma
Glucagonoma
Insulinoma
Metastatic Gast...
Pancreatic Poly...
Pulmonary Carci...
Recurrent Gastr...
Recurrent Islet...
Regional Gastro...
Somatostatinoma
romidepsin
laboratory biom...
18 Years - National Cancer Institute (NCI) View Everolimus in Patients With Pancreatic Neuroendocrine Tumors Metastatic to the Liver Previously Treated With Surgery NCT02031536 Gastrinoma
Glucagonoma
Insulinoma
Liver Metastase...
Pancreatic Poly...
Recurrent Islet...
Somatostatinoma
everolimus
placebo
18 Years - Eastern Cooperative Oncology Group View Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer NCT00096083 Cancer
isolated perfus...
melphalan
16 Years - Delcath Systems Inc. View Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors NCT00084461 Gastrinoma
Glucagonoma
Insulinoma
Metastatic Gast...
Pancreatic Poly...
Pulmonary Carci...
Recurrent Gastr...
Recurrent Islet...
Regional Gastro...
Somatostatinoma
romidepsin
laboratory biom...
18 Years - National Cancer Institute (NCI) View Capecitabine, Temozolomide, and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors NCT01525082 Gastrinoma
Glucagonoma
Insulinoma
Pancreatic Poly...
Recurrent Islet...
Recurrent Pancr...
Somatostatinoma
Stage III Pancr...
Stage IV Pancre...
Capecitabine
Temozolomide
Bevacizumab
18 Years - Stanford University View Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors NCT01824875 Gastrinoma
Glucagonoma
Insulinoma
Islet Cell Carc...
Pancreatic Poly...
Recurrent Islet...
Somatostatinoma
temozolomide
capecitabine
18 Years - Eastern Cooperative Oncology Group View